Literature DB >> 11768744

Acute thrombotic occlusion of the left main coronary artery in a hypercoagulable patient treated with intracoronary abciximab.

J D Schlaifer1, W Horgan, M J Malkowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11768744      PMCID： PMC6654839          DOI： 10.1002/clc.4960241208

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN： 0160-9289            Impact factor:   2.882


× No keyword cloud information.
  7 in total

1.  Myocardial infarction associated with thrombus formation in non-culprit coronary arteries.

Authors:  Bilal Boztosun; Emre Gurel; Yilmaz Gunes; Ayhan Olcay
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

2.  Left main coronary artery thrombus: a case series with different outcomes.

Authors:  Rajiv Gupta; Mohammed A Rahman; Barry F Uretsky; Ernst R Schwarz
Journal:  J Thromb Thrombolysis       Date:  2005-04       Impact factor: 2.300

3.  Catheter-Directed Intra-Arterial Abciximab Administration for Acute Thrombotic Occlusions during Neurointerventional Procedures.

Authors:  I C Duncan; P A Fourie
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

Review 4.  Rationale for intracoronary administration of abciximab.

Authors:  Enrico Romagnoli; Francesco Burzotta; Carlo Trani; Giuseppe G L Biondi-Zoccai; Floriana Giannico; Filippo Crea
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

Review 5.  Evaluation of thrombotic left main coronary artery occlusions; old problem, different treatment approaches.

Authors:  Murat Akcay
Journal:  Indian Heart J       Date:  2017-09-14

Review 6.  Low-Dose Slow Infusion Tissue Plasminogen Activator (tPA) in Treatment of Thrombotic Coronary Artery Occlusions: Case Series and Literature Review.

Authors:  Murat Akçay; Metin Çoksevim; Ufuk Yıldırım; Ömer Gedikli; Okan Gülel; Serkan Yüksel; Murat Meriç; Korhan Soylu; Özcan Yılmaz; Mahmut Şahin
Journal:  Anatol J Cardiol       Date:  2022-04       Impact factor: 1.475

Review 7.  Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives.

Authors:  Artur Dziewierz; Tomasz Rakowski; Dariusz Dudek
Journal:  Ther Clin Risk Manag       Date:  2014-07-18       Impact factor: 2.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.